Early postoperative pelvic-floor biofeedback improves erectile function in men undergoing radical prostatectomy: a prospective, randomized, controlled trial
Carregando...
Citações na Scopus
39
Tipo de produção
article
Data de publicação
2012
Editora
NATURE PUBLISHING GROUP
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
RIBEIRO, L. H. S.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, v.24, n.5, p.174-178, 2012
Resumo
Erectile dysfunction (ED) and urinary incontinence are common complications following radical prostatectomy (RP). Although pelvic-floor biofeedback training (PFBT) may improve urinary continence following RP, its effects on the recovery of potency are unknown. Fifty-two patients selected for RP were prospectively randomized for a treatment group (n=26) receiving PFBT once a week for 3 months and home exercises or a control group (n=26), in which patients received verbal instructions to contract the pelvic floor. Erectile function (EF) was evaluated with the International Index of Erectile Function-5 (IIEF-5) before surgery and 1, 3, 6 and 12 months postoperatively. Patients were considered potent when they had a total IIEF-5 score >20. Continence status was assessed and defined as the use of no pads. Groups were comparable in terms of age, body mass index, diabetes, pathological tumor stage and neurovascular bundle preservation. A significant reduction in IIEF-5 scores was observed after surgery in both groups. In the treatment group, 8 (47.1%) patients recovered potency 12 months postoperatively, as opposed to 2 (12.5%) in the control group (P=0.032). The absolute risk reduction was 34.6% (95% confidence interval (CI): 3.8-64%) and the number needed to treat was 3 (95% CI: 1.5-17.2). A strong association between recovery of potency and urinary continence was observed, with continent patients having a 5.4 higher chance of being potent (P=0.04). Early PFBT appears to have a significant impact on the recovery of EF after RP. Urinary continence status was a good indicator of EF recovery, with continent patients having a higher chance of being potent.
Palavras-chave
biofeedback, erectile dysfunction, prostatectomy, urinary incontinence
Referências
- Burkhard FC, 2006, J UROLOGY, V176, P189, DOI 10.1016/S0022-5347(06)00574-X
- Burnett AL, 2006, J UROLOGY, V176, P882, DOI 10.1016/j.juro.2006.04.020
- Burnett AL, 2007, J UROLOGY, V178, P597, DOI 10.1016/j.juro.2007.03.140
- CLAES H, 1993, BRIT J UROL, V71, P52, DOI 10.1111/j.1464-410X.1993.tb15880.x
- Dorey G, 2004, BRIT J GEN PRACT, V54, P819
- Dorey Grace, 2003, J Wound Ostomy Continence Nurs, V30, P44, DOI 10.1067/mjw.2003.7
- Dorey Grace, 2007, Br J Nurs, V16, P1194
- Dubbelman YD, 2006, EUR UROL, V50, P711, DOI 10.1016/j.eururo.2006.06.009
- Fandel TM, 2008, J SEX MED, V5, P1866, DOI 10.1111/j.1743-6109.2008.00881.x
- Filocamo MT, 2005, EUR UROL, V48, P734, DOI 10.1016/j.eururo.2005.06.004
- Hinh P, 2008, ADV UROL
- Hsieh PS, 2003, BJU INT, V92, P470, DOI 10.1046/j.1464-410X.2003.04373.x
- Kao TC, 2000, J UROLOGY, V163, P858, DOI 10.1016/S0022-5347(05)67819-6
- Kaufmann O, 2008, BJU INT, V102, P1026, DOI 10.1111/j.1464-410X.2008.07760.x
- Kendirci M, 2006, CURR OPIN UROL, V16, P186, DOI 10.1097/01.mou.0000193407.05285.d8
- Kundu SD, 2004, J UROLOGY, V172, P2227, DOI 10.1097/01.ju.0000145222.94455.73
- LAVOISIER P, 1988, J UROLOGY, V139, P176
- LAVOISIER P, 1986, J UROLOGY, V136, P936
- Loppenberg B, 2010, J UROLOGY, V184, P944, DOI 10.1016/j.juro.2010.05.032
- Loughlin KR, 2010, J UROLOGY, V183, P871, DOI 10.1016/j.juro.2009.11.011
- Marien T, 2009, J UROLOGY, V181, P1817, DOI 10.1016/j.juro.2008.11.105
- Marien TP, 2008, BJU INT, V102, P1581, DOI 10.1111/j.1464-410X.2008.07921.x
- Matthews VB, 2009, DIABETOLOGIA, V52, P1409, DOI 10.1007/s00125-009-1364-1
- McCullough Andrew R, 2005, Rev Urol, V7 Suppl 2, pS3
- McCullough AR, 2010, J UROLOGY, V183, P2451, DOI 10.1016/j.juro.2010.01.062
- McCullough AR, 2008, J SEX MED, V5, P476, DOI 10.1111/j.1743-6109.2007.00700.x
- Michl UHG, 2006, J UROLOGY, V176, P227, DOI 10.1016/S0022-5347(06)00632-X
- Miles CL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005540.pub2
- Montorsi F, 2008, EUR UROL, V54, P924, DOI 10.1016/j.eururo.2008.06.083
- Montorsi F, 1997, J UROLOGY, V158, P1408, DOI 10.1016/S0022-5347(01)64227-7
- Mulhall JP, 2009, J UROLOGY, V181, P462, DOI 10.1016/j.juro.2008.10.047
- Mulhall JP, 2007, J SEX MED, V4, P538, DOI 10.1111/j.1743-6109.2007.00486.x
- Nehra A, 2005, J UROLOGY, V173, P2067, DOI 10.1097/01.ju.0000158456.41788.93
- Noldus J, 2002, EUR UROL, V42, P118, DOI 10.1016/S0302-2838(02)00219-1
- Padma-Nathan H, 2008, INT J IMPOT RES, V20, P479, DOI 10.1038/ijir.2008.33
- Penson DF, 2005, J UROLOGY, V173, P1701, DOI 10.1097/01.ju.0000154637.38262.3a
- Raina R, 2006, INT J IMPOT RES, V18, P77, DOI 10.1038/sj.ijir.3901380
- Raina R, 2007, BJU INT, V100, P1317, DOI 10.1111/j.1464-410X.2007.07124.x
- Ribeiro LHS, 2010, J UROLOGY, V184, P1034, DOI 10.1016/j.juro.2010.05.040
- Rosen RC, 1999, INT J IMPOT RES, V11, P319
- Salomon G, 2009, J SEX MED, V6, P498, DOI 10.1111/j.1743-6109.2008.01089.x
- Saranchuk JW, 2005, J CLIN ONCOL, V23, P4146, DOI 10.1200/JCO.2005.12.922
- Stanford JL, 2000, JAMA-J AM MED ASSOC, V283, P354, DOI 10.1001/jama.283.3.354
- Treiyer A, 2011, J UROLOGY, V185, P1681, DOI 10.1016/j.juro.2010.12.052
- Van Kampen M, 2003, PHYS THER, V83, P536
- von Bodman C, 2011, J SEX MED, V8, P567, DOI 10.1111/j.1743-6109.2010.01911.x
- WALSH PC, 1987, J UROLOGY, V138, P823
- WESPES E, 1990, EUR UROL, V18, P45
- Yossepowitch O, 2007, J UROLOGY, V178, P493, DOI 10.1016/j.juro.2007.03.105